GN

Greenrose Holding Company IncOOTC GNRS Stock Report

Last reporting period 30 Sep, 2022

Updated —

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

GNRS Stock Analysis

GN

Uncovered

Greenrose Holding Company Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-40/100

Low score

Market cap $B

0

Dividend yield

Shares outstanding

17.65 B

The Greenrose Holding Co., Inc. engages in the manufacture and processing of cannabis and cannabinoid-based products for the medical cannabis marketplace. The company is headquartered in Woodbury, New York and currently employs 6 full-time employees. The company went IPO on 2020-02-11. The Company, through its subsidiaries, Theraplant, LLC and True Harvest LLC is engaged in the manufacture and processing of cannabis in the adult-use and medical cannabis marketplace in Connecticut and Arizona. The company owns and operates cannabis businesses or has management or consulting services or other agreements to assist in operations with licensed operators. The firm is focused on providing access to the cannabis and cannabinoid-based products through cultivation and processing facilities and customer engagement channels, in store, online and at home. Its primary areas of focus include cultivation and genetics; retail and distribution; processing/manufacturing; wholesale; and data and insights. The firm has approximately 63,500 square feet of canopy for cannabis cultivation.

View Section: Eyestock Rating